Soturi

Digital

Soturi, Newel Health’s digital therapeutics solution for Parkinson’s Disease (PD), has begun the next phase of development, aiming to v

Digital

Partner Content

Newel Health has been awarded a $2.5 million research grant from The Michael J. Fox Foundation.

News

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.